Similar articles for PMID: 36302655

Year	Number of Results
2009	2
2010	2
2011	2
2012	3
2013	2
2014	1
2015	3
2016	5
2017	8
2018	14
2019	16
2020	22
2021	20
2022	17
2023	17
2024	19

1

Preclinical Evaluation of ⁸⁹Zr-Desferrioxamine-Bexmarilimab, a Humanized Antibody Against Common Lymphatic Endothelial and Vascular Endothelial Receptor-1, in a Rabbit Model of Renal Fibrosis.

Moisio O, Virta J, Yatkin E, Liljenbäck H, Palani S, Viitanen R, Miner MWG, Oikonen V, Tolvanen T, Vugts DJ, Taimen P, Li XG, Hollmén M, Jalkanen S, Roivainen A. Moisio O, et al. J Nucl Med. 2023 Apr;64(4):555-560. doi: 10.2967/jnumed.122.264725. Epub 2022 Oct 27. J Nucl Med. 2023. PMID: 36302655 Free PMC article.

2

CD4⁺ and CD8a⁺ PET imaging predicts response to novel PD-1 checkpoint inhibitor: studies of Sym021 in syngeneic mouse cancer models.

Kristensen LK, Fröhlich C, Christensen C, Melander MC, Poulsen TT, Galler GR, Lantto J, Horak ID, Kragh M, Nielsen CH, Kjaer A. Kristensen LK, et al. Theranostics. 2019 Oct 18;9(26):8221-8238. doi: 10.7150/thno.37513. eCollection 2019. Theranostics. 2019. PMID: 31754392 Free PMC article.

3

Immuno-PET Imaging of CD30-Positive Lymphoma Using 89Zr-Desferrioxamine-Labeled CD30-Specific AC-10 Antibody.

Rylova SN, Del Pozzo L, Klingeberg C, Tönnesmann R, Illert AL, Meyer PT, Maecke HR, Holland JP. Rylova SN, et al. J Nucl Med. 2016 Jan;57(1):96-102. doi: 10.2967/jnumed.115.162735. Epub 2015 Oct 29. J Nucl Med. 2016. PMID: 26514172 Free article.

4

Advancing ⁸⁹Zr-immuno-PET in neuroscience with a bispecific anti-amyloid-beta monoclonal antibody - The choice of chelator is essential.

Wuensche TE, Stergiou N, Mes I, Verlaan M, Schreurs M, Kooijman EJM, Janssen B, Windhorst AD, Jensen A, Asuni AA, Bang-Andersen B, Beaino W, Dongen GAMS, Vugts DJ. Wuensche TE, et al. Theranostics. 2022 Oct 9;12(16):7067-7079. doi: 10.7150/thno.73509. eCollection 2022. Theranostics. 2022. PMID: 36276653 Free PMC article.

5

Development of a Specifically Labeled ⁸⁹Zr Antibody for the Noninvasive Imaging of Tumors Overexpressing B7-H3.

Zheng M, Liu Q, Zhang H, Wang Y, Zhang K, Mu H, Fu F, Zhang X, Wang Y, Miao L. Zheng M, et al. Mol Pharm. 2024 Oct 7;21(10):5205-5216. doi: 10.1021/acs.molpharmaceut.4c00597. Epub 2024 Sep 25. Mol Pharm. 2024. PMID: 39322604

6

A comparison of DFO and DFO* conjugated to trastuzumab-DM1 for complexing ⁸⁹Zr - In vitro stability and in vivo microPET/CT imaging studies in NOD/SCID mice with HER2-positive SK-OV-3 human ovarian cancer xenografts.

Cho H, Al-Saden N, Lam H, Möbus J, Reilly RM, Winnik MA. Cho H, et al. Nucl Med Biol. 2020 May-Jun;84-85:11-19. doi: 10.1016/j.nucmedbio.2019.12.009. Epub 2019 Dec 30. Nucl Med Biol. 2020. PMID: 31931305

7

Evaluation of PET/CT imaging with [89Zr]Zr-DFO-girentuximab: a phase 1 clinical study in Japanese patients with renal cell carcinoma (Zirdac-JP).

Nakaigawa N, Hasumi H, Utsunomiya D, Yoshida K, Ishiwata Y, Oka T, Hayward C, Makiyama K. Nakaigawa N, et al. Jpn J Clin Oncol. 2024 Aug 14;54(8):873-879. doi: 10.1093/jjco/hyae075. Jpn J Clin Oncol. 2024. PMID: 38864246 Free PMC article. Clinical Trial.

8

Preclinical Development of CD38-Targeted [⁸⁹Zr]Zr-DFO-Daratumumab for Imaging Multiple Myeloma.

Ghai A, Maji D, Cho N, Chanswangphuwana C, Rettig M, Shen D, DiPersio J, Akers W, Dehdashti F, Achilefu S, Vij R, Shokeen M. Ghai A, et al. J Nucl Med. 2018 Feb;59(2):216-222. doi: 10.2967/jnumed.117.196063. Epub 2017 Oct 12. J Nucl Med. 2018. PMID: 29025987 Free PMC article.

9

Zirconium- 89 Labeled Antibody K1-70 for PET Imaging of Thyroid-stimulating Hormone Receptor Expression in Thyroid Cancer.

Parent EE, Gleba JJ, Knight JA, Kenderian SJ, Copland JA 3rd, Cai H. Parent EE, et al. Mol Imaging Biol. 2024 Oct;26(5):847-857. doi: 10.1007/s11307-024-01945-7. Epub 2024 Aug 22. Mol Imaging Biol. 2024. PMID: 39174789

10

Total-Body PET and Highly Stable Chelators Together Enable Meaningful ⁸⁹Zr-Antibody PET Studies up to 30 Days After Injection.

Berg E, Gill H, Marik J, Ogasawara A, Williams S, van Dongen G, Vugts D, Cherry SR, Tarantal AF. Berg E, et al. J Nucl Med. 2020 Mar;61(3):453-460. doi: 10.2967/jnumed.119.230961. Epub 2019 Sep 27. J Nucl Med. 2020. PMID: 31562219 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 36302655

128 results

Results by year